Top 10 articles in February

We’ve had a big February. Thanks to our growing number of visitors we have increased our traffic by 290% in one month. Boom.

Thanks for your support. Don’t forget you can register for daily updates here.  

What interested you most in the world of Longevity last month? Here’s your top 10:

  1. Proving the Longevity potential of NAD+
  2. 114 year-old cells converted to pluripotent stem cells
  3. New imaging technique progresses organ growth
  4. Anti-aging drugs in MIT’s 10 Breakthrough Technologies 2020
  5. LSD = Longevity (and) stalled dementia?
  6. FDA-approved drug slows cellular aging
  7. Pathway to Longevity: get rid of zombie cells
  8. Hormone producing organoids to halt age-related disease
  9. Fishing for regenerative therapies
  10. Rejuvant shows positive early results in humans

Oh, and if you have interesting news or insights to share with the Longevity.Technology team you can submit here. Thanks!

Phil Newman
Editor-in-Chief Phil has over 25 years of C-level management, marketing and business development expertise in Europe and North America. His creative background has helped him shape unconventional strategies for commercial growth - garnering both awards and investor ROI.

Phil has wide experience of technology transfer and the commercialisation of innovations from both private and institutional sources and this led to his interest in Longevity and the founding of Longevity.Technology.

Latest articles

eGenesis’ xenotransplantation trials move closer to in-human

eGenesis' groundbreaking xenotransplantation work with Massachusetts General Hospital to be expanded through additional collaboration. eGenesis has announced it is expanding its research collaboration with the...

New Japanese stem cell clinical trial for aging frailty

Longeveron announces Phase 2 clinical trial to evaluate the safety and efficacy of Mesenchymal Stem Cells (LMSCs) for the treatment of aging frailty in...

Unlocking the Longevity potential of our oceans

Biologist focuses on the coast of Oman to discover how extreme environments and oceanic life could provide sources for Longevity. With issues like climate change, overfishing...

Alkahest announces phase 2 study treatment of cognitive impairment

Extra-corporeal medical device could improve neuro outlook for end-stage renal disease patients. Alkahest has announced its first foray into dialysis-associated dementia with a new randomised,...